Looking forward to the 2025 prediction season, a survey of the emerging AI-powered drug discovery landscape has been making the rounds—and with good reason. The survey, summarized by Stanford’s Chris Bradbury, is likely the...more
12/19/2024
/ Artificial Intelligence ,
Automation Systems ,
Confidential Information ,
Cybersecurity ,
Data Collection ,
Food and Drug Administration (FDA) ,
Information Governance ,
Intellectual Property Protection ,
Medical Devices ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Privacy Laws ,
Proprietary Information ,
Regulatory Requirements ,
Trade Secrets
In our ever-changing technological environment, artificial intelligence (AI) is beginning to exert its influence on numerous sectors, revolutionizing our approach to work. As businesses and organizations worldwide adopt...more
10/12/2023
/ Anti-Discrimination Policies ,
Artificial Intelligence ,
Automated Decision Systems (ADS) ,
Bias ,
Biotechnology ,
Compliance ,
Confidential Information ,
Discrimination ,
Due Diligence ,
Equal Employment Opportunity Commission (EEOC) ,
Federal Trade Commission (FTC) ,
Insurance Industry ,
Intellectual Property Protection ,
Investors ,
Machine Learning ,
Misrepresentation ,
New Guidance ,
Patents ,
Personal Data ,
Purchase Agreement ,
Risk Management ,
Risk Mitigation ,
Startups ,
Strict Product Liability ,
Transparency ,
Venture Capital
Various types of intellectual property (IP) can provide companies protection of innovations and maintain or expand competitive advantages. For companies that operate using Software-as-a-Service (SaaS) technologies and/or...more
11/9/2022
/ Cloud Computing ,
Confidential Information ,
Copyright ,
Design Patent ,
Intellectual Property Protection ,
Open Source Software ,
Patents ,
SaaS ,
Trade Secrets ,
Trademarks ,
Utility Patents